Fidelity International
IMGN

Fidelity International’s Immunogen Inc IMGN Stock Holding History

Fidelity International’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,360,000
Closed -$159M – 906
2023
Q4 		$159M Buy
+5,360,000
New +$107M 0.17% 153

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity International's IMGN Position: Q1 2024 in Review

Fidelity International sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 5,360,000 shares — an estimated $159M sold.

Fidelity International first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $159M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Fidelity International reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Fidelity International sold 5,360,000 Immunogen Inc shares in Q1 2024, an estimated $159M.
  • Fidelity International first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Fidelity International's Immunogen Inc position peaked at $159M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Fidelity International's 13F filing for Q1 2024, filed 13 May 2024.